CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Shares withheld for taxes Chief Medical Officer gave up 10,203 shares (to pay taxes)
- 4 Grant or award Chief Legal Officer&Secretary acquired 1,200,000 shares (grant or award)
- 4 Grant or award Executive President acquired 600,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 950,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 1,820,000 shares (grant or award)
- 8-K Event Results of operations · Auditor change
- 10-K Report Annual Report
- 4 Insider Changes in Ownership
- 8-K Event Executive or director change
- 4 Shares withheld for taxes Chief Executive Officer gave up 12,612 shares (to pay taxes)
- 4 Grant or award VP, Controller&Acct Principal acquired 403,430 shares (grant or award)
- 4 Shares withheld for taxes Chief Medical Officer gave up 118,143 shares (to pay taxes)
- 8-K Event Shareholder rights changed
- 4 Shares withheld for taxes Chief Executive Officer gave up 18,734 shares (to pay taxes)
- 8-K Event Other events
- 4 Shares withheld for taxes Chief Executive Officer gave up 190,287 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 22 of 26 · 506 filings